Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:6.1.1.18 (
glutaminyl-tRNA synthetase
)
231
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Glutaminyl-tRNA synthetase from Escherichia coli is a member of a subgroup of aminoacyl-tRNA synthetases that do not catalyze ATP-PPi exchange in the absence of the cognate tRNA. Such behavior suggests conformational changes upon substrate binding. Two different fluorescent probes, pyrenylmaleimide and acrylodan, were used to specifically label a nonessential sulfhydryl group of
GlnRS
. Conformational changes induced by substrates were studied using
glutaminyl-tRNA synthetase
labeled with these two environment-sensitive probes. ATP was shown to cause a significant conformational change that alters the mode of binding to tRNA(Gln) to
GlnRS
. The alteration of the
salt
sensitivity pattern of tRNA(Gln) binding to
GlnRS
by ATP supports this. Binding of tRNA(Gln) causes a conformational change that may be different in nature for the ATP/
GlnRS
complex and free
GlnRS
. Hydrodynamic parameters deduced from fluorescence polarization studies and the use of a noncovalent probe indicate that the ATP-induced conformational change may not be global in character.
...
PMID:A fluorescence spectroscopic study of substrate-induced conformational changes in glutaminyl-tRNA synthetase. 836 95